Canopy Growth Corp vs MasterCard Inc — how do they compare? Canopy Growth Corp trades at $0.97 (market cap $398.46M), while MasterCard Inc trades at $538.89 (market cap $475.39B). The key difference: MasterCard Inc is far larger — about 1193.1× Canopy Growth Corp's market cap, and MasterCard Inc pays a 0.65% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | MA | |
|---|---|---|
Market Cap | $398.46M | $475.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.92 | $598.96 |
52-Week Low | $0.86 | $471.55 |
Enterprise Value | $337.90M | $486.13B |
Volume | — | 4,635,698 |
Dividend Yield | — | 0.65% |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Mastercard (MA) trades at $537.70, up 2.08% with strong bullish momentum supported by consistent earnings beats and robust financial performance. The stock shows impressive profitability with 45.88% net margins and 232.56% ROE, though valuation multiples remain elevated. Recent institutional buying activity and overwhelmingly positive analyst sentiment reinforce the bullish case, with a consensus price target of $634.27 representing 18% upside potential.
Mastercard's outlook remains positive with strong revenue growth and expanding margins, though premium valuation and emerging payment competition pose risks. The company's aggressive AI investments and global expansion initiatives support continued growth, while stable dividend payments provide shareholder returns. Investors should weigh the stock's quality fundamentals against its rich valuation in current market conditions.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →